Roche Acquires Carmot Therapeutics for $2.7 Billion

Roche Acquires Carmot Therapeutics for $2.7 Billion

by | Dec 4, 2023 10:39 am | Biotechnology

Carmot Therapeutics Inc. announced on December 4 that it entered into a definitive merger agreement to be acquired by Roche Holding AG at a purchase price of $2.7 billion upfront and the potential for $400 million in milestone payments.  Carmot Therapeutics is a biotechnology firm with injectable dual GLP-1/GIP receptor agonists and an oral GLP-1 drug in clinical development. The biotechnology company filed to go public in November 2023.  Roche Holding AG, commonly known as Roche, operates in the pharmaceuticals and diagnostics businesses worldwide. The company’s headquarters are located in Basel, Switzerland. According to its 2022 annual report, Roche’s net sales... Read More »
Roche Acquires Carmot Therapeutics for $2.7 Billion

AbbVie Acquires ImmunoGen for $10.1 Billion, Expanding Solid Tumor Portfolio

by | Nov 30, 2023 12:28 pm | Biotechnology

AbbVie Inc. and ImmunoGen, Inc. announced on November 30 a definitive agreement under which AbbVie will acquire ImmunoGen, a publicly traded biotechnology company focused on the development of antibody-drug conjugate (ADC) technology to treat cancer.  Under the terms of the transaction, AbbVie will acquire all outstanding shares of ImmunoGen for $31.26 per share in cash. The transaction values ImmunoGen at a total equity value of approximately $10.1 billion.  ImmunoGen’s flagship cancer therapy ELAHERE® (mirvetuximab soravtansine-gynx) is approved for the treatment of platinum-resistant ovarian cancer. According to its 2022 financial report, ImmunoGen had total revenues of... Read More »
Healthpeak Properties and Physicians Realty Trust Announce $21 Billion Merger

Healthpeak Properties and Physicians Realty Trust Announce $21 Billion Merger

by | Oct 30, 2023 12:44 pm | Medical Office Buildings, Other Services

Healthpeak Properties and Physicians Realty Trust announced on October 30 that they have entered into a definitive agreement to combine in an all-stock merger of equals valued at approximately $21 billion.  According to data captured in the LevinPro HC database, this transaction marks the second largest healthcare transaction of 2023 by purchase price, behind Pfizer’s $43 billion acquisition of Seagen Inc. announced in March.  Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. According to its 2022 financial... Read More »

Medtronic Swoons over HeartWare

by | Jun 29, 2016 8:00 am | Medical Devices

Medtronic plc (NYSE: MDT) kept up its busy acquisition pace, notching its fifth deal in 2016. The target is HeartWare International (NASDAQ: HTWR), developer and maker of miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure. Its lead product is the HVAD® System, featuring the world’s smallest full-support ventricular assist device. Medtronic will pay $58.00 per share in cash for all outstanding common stock in HeartWare, for a transaction value of $1.1 billion. This acquisition will expand Medtronic’s portfolio of diagnostic tools, therapies and services for patients suffering from heart failure. The transaction is... Read More »